subscribe
 

Keep up to speed with Lonza’s free Resource Notes™ journal

With the slogan “Science Doesn't Slow Down, and Neither Should You”, Lonza invites its customers to subscribe to the company’s free...

Lab Innovations 2013 to almost double in size

When Lab Innovations - the UK’s only show dedicated to the latest laboratory technology & consumables, analytical & biotech equipment – returns to the NEC, Birmingham on 6 & 7 November the event will be 75% bigger, with over 100 of the...

Polyphor achieves first milestone in macrocycle drug discovery collaboration with Boehringer Ingelheim

Polyphor, a research-driven pharmaceutical company and leader in the discovery and development of macrocyclic drugs, has announced that Boehringer Ingelheim has decided to enter into the next stage of its drug discovery collaboration with...

India Lab Expo

India Lab Expo is the biggest exhibition in South East Asia for laboratory, analytical, biotechnology, life science, material testing, and laboratory consumable products & Instruments.

Novartis receives positive CHMP opinion for Ilaris®

Novartis receives positive CHMP opinion for Ilaris® in active Systemic Juvenile Idiopathic Arthritis, a serious form of childhood arthritis.

Cheaper anti-cancer drug as effective as expensive drug in treating most common cause of blindness in older adults

An anti-cancer drug has been proven to be equally as effective in treating the most common cause of blindness in older adults as a more expensive drug specifically formulated for this purpose.

Roche launches new ProGRP test for more precise diagnosis in lung cancer

New test expands cancer diagnostics portfolio and strengthens Roche Diagnostics’ comprehensive tumour marker menu.

OG flowmeters for monitoring viscous flows

High-precision Oval Gear (OG) flowmeters from Titan Enterprises can monitor a viscous fluid flow at flow rates up to 500l/min, using...

Galen acquires Synera® (lidocaine 70mg/tetracaine 70mg) topical patch

Galen, a Northern Ireland based pharmaceutical company, has acquired Synera® (lidocaine 70mg/tetracaine 70mg) topical patch from ZARS Pharma Inc., a wholly owned subsidiary of Nuvo Research Inc.

The Scientist Best Place to Work

Wyatt Technology Corporation, the world leader in absolute macromolecular characterization instrumentation and software, announces it has been ranked among The Scientist magazine’s Best Places to Work in Industry, for the fifth...

Roche halts investigation of aleglitazar

Roche has announced that following the results of a regular safety review of the aleglitazar AleCardio phase III trial, the independent Data and Safety Monitoring Board (DSMB) has recommended to halt the trial due to safety signals and lack...

Scientists develop ground-breaking new method of ‘starving’ cancer cells

A University of Southampton Professor, in collaboration with colleagues at the BC Cancer Agency Research Centre, have discovered a novel way...

Staphylococcus aureus vaccine

A consortium comprising Imaxio, the Jenner Institute at Oxford University, the European Vaccine Initiative and Preclin Biosystems has been awarded a major FP7 grant to support development and phase I clinical trial of an S. aureus vaccine.

3D spheroid assays for cancer drug screening

AMSBIO has introduced a new range of 96-well format 3D Spheroid Cell Proliferation / Viability Assays, providing a new tool to allow...

Antibiotics may increase eczema risk in children, study reveals

Use of antibiotics in early life may increase the risk of developing eczema by up to 40 per cent, according to a new study involving researchers from The University of Nottingham, in the British Journal of Dermatology.

New 10-Plate petri dish racks and coloured tags

Don Whitley Scientific Limited (DWS) has this week launched a new 10-Plate Petri Dish Rack made from stainless steel.

Join Lonza’s free webinar on convenient and efficient non-viral iPSC generation

The first webinar is scheduled for 18 June 2013 at 10 AM CEST (Berlin). The second session will be held on 19 June 2013 at 2 PM EDT (New York).

Cobra Biologics and Novolytics unveil successful development of bacteriophages against bacterial infection

Cobra Biologics and Novolytics have announced a breakthrough in the development of two Staphylococcus aureus based phage products for Phase I clinical trials with a 100 fold increase in upstream process yields.

Roche's RoACTEMRA approved in EU to treat children with rare form of arthritis

Roche has announced that the European Medicines Agency has approved RoACTEMRA to treat children with polyarticular juvenile idiopathic arthritis (PJIA), a rare, chronic and debilitating form of childhood arthritis.

New 2-3 day patient-applied product for sun-damaged skin that can lead to skin cancer

A new treatment for sun-damaged skin that can lead to skin cancer is launched by LEO Pharma

Pages

Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe